G. Pianetti

Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome.

G. Remuzzi, J. Atkinson, M. Noris, 2006, Blood.

The complement factor H R1210C mutation is associated with atypical hemolytic uremic syndrome.

G. Remuzzi, P. Zipfel, C. Skerka, 2008, Journal of the American Society of Nephrology : JASN.

Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome.

J. Atkinson, M. Noris, V. Frémeaux-Bacchi, 2007, Blood.

Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype.

G. Remuzzi, P. Zipfel, I. M. van der Meer, 2010, Clinical journal of the American Society of Nephrology : CJASN.

Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: the C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease.

G. Remuzzi, E. Daina, M. Noris, 2003, Human molecular genetics.

Genetic analysis of the complement factor H related 5 gene in haemolytic uraemic syndrome.

G. Remuzzi, M. Noris, E. Bresin, 2007, Molecular immunology.

presentation, response to treatment, and outcome Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical

G. Remuzzi, J. Atkinson, M. Noris, 2013 .

syndrome syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP Membrane cofactor protein mutations in atypical hemolytic uremic

J. Atkinson, M. Noris, V. Frémeaux-Bacchi, 2013 .

Prevention of transfusion‐associated Chagas' disease by sterilization of Trypanosoma cruzi‐infected blood with gentian violet, ascorbic acid, and light

E. Lages-Silva, H. Moraes-Souza, J. Bordin, 1995, Transfusion.